123 related articles for article (PubMed ID: 8194366)
1. Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields.
Pleyer U; Elkins B; Rückert D; Lutz S; Grammer J; Chou J; Schmidt KH; Mondino BJ
Curr Eye Res; 1994 Mar; 13(3):177-81. PubMed ID: 8194366
[TBL] [Abstract][Full Text] [Related]
2. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
Kanpolat A; Batioglu F; Yilmaz M; Akbas F
CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
[TBL] [Abstract][Full Text] [Related]
3. Collagen as a delivery system for hydrophobic drugs: studies with cyclosporine.
Gebhardt BM; Kaufman HE
J Ocul Pharmacol Ther; 1995; 11(3):319-27. PubMed ID: 8590264
[TBL] [Abstract][Full Text] [Related]
4. The collagen shield. A new vehicle for delivery of cyclosporin A to the eye.
Reidy JJ; Gebhardt BM; Kaufman HE
Cornea; 1990 Jul; 9(3):196-9. PubMed ID: 2373013
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
[TBL] [Abstract][Full Text] [Related]
6. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
[TBL] [Abstract][Full Text] [Related]
7. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye.
Pleyer U; Lutz S; Jusko WJ; Nguyen KD; Narawane M; Rückert D; Mondino BJ; Lee VH; Nguyen K
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2737-42. PubMed ID: 7688360
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
[TBL] [Abstract][Full Text] [Related]
9. Ocular distribution of cyclosporin A (Sandimmun) following systemic and topical administration to rabbits.
Vernillet L; Lundh RL; Acezat-Mispelter F; Goizel C; Humbert H; Pouliquen Y
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():150-8. PubMed ID: 1820870
[TBL] [Abstract][Full Text] [Related]
10. Collagen shields and intraocular drug delivery: concentration of gentamicin in the aqueous and vitreous of a rabbit eye after lensectomy and vitrectomy.
Baziuk N; Gremillion CM; Peyman GA; Cho HK
Int Ophthalmol; 1992 Mar; 16(2):101-7. PubMed ID: 1587692
[TBL] [Abstract][Full Text] [Related]
11. Collagen shield delivery of amphotericin B.
Schwartz SD; Harrison SA; Engstrom RE; Bawdon RE; Lee DA; Mondino BJ
Am J Ophthalmol; 1990 Jun; 109(6):701-4. PubMed ID: 2346199
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes.
Theng JT; Ti SE; Zhou L; Lam KW; Chee SP; Tan D
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4895-9. PubMed ID: 14578414
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A delivery to the eye: a pharmaceutical challenge.
Lallemand F; Felt-Baeyens O; Besseghir K; Behar-Cohen F; Gurny R
Eur J Pharm Biopharm; 2003 Nov; 56(3):307-18. PubMed ID: 14602172
[TBL] [Abstract][Full Text] [Related]
14. Noncross-linked collagen discs and cross-linked collagen shields in the delivery of gentamicin to rabbits eyes.
Liang FQ; Viola RS; del Cerro M; Aquavella JV
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2194-8. PubMed ID: 1607229
[TBL] [Abstract][Full Text] [Related]
15. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
Weiss SL; Kramer WG
J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
[No Abstract] [Full Text] [Related]
16. Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit.
Lehr CM; Lee YH; Lee VH
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2809-14. PubMed ID: 8188475
[TBL] [Abstract][Full Text] [Related]
17. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
Hariprasad SM; Shah GK; Chi J; Prince RA
J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
[TBL] [Abstract][Full Text] [Related]
18. Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.
Cholkar K; Gilger BC; Mitra AK
Transl Vis Sci Technol; 2015 May; 4(3):1. PubMed ID: 25964868
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
20. Collagen shields impregnated with gentamicin-dexamethasone as a potential drug delivery device.
Milani JK; Verbukh I; Pleyer U; Sumner H; Adamu SA; Halabi HP; Chou HJ; Lee DA; Mondino BJ
Am J Ophthalmol; 1993 Nov; 116(5):622-7. PubMed ID: 8238224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
